Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular

PUBLISHER: Grand View Research | PRODUCT CODE: 1790389

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1790389

Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Services (Endovascular Devices, Surgical Devices), By Anatomical Site (Aortoiliac, Femoropopliteal), By End-use, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Peripheral Artery Disease Market Summary

The global peripheral artery disease market size was estimated at USD 7.3 billion in 2024 and is projected to reach USD 11.3 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. The intersecting forces of rising disease burden, continuous technological advancement, and demographic aging drive the peripheral artery disease (PAD) industry.

This alignment of unmet clinical needs with evolving therapeutic capabilities accelerates demand across care settings. The growing prevalence of diabetes and tobacco use remains a foundational force driving the market. Both risk factors contribute directly to the progression of atherosclerosis, the core pathological mechanism behind PAD. With diabetes rates climbing globally-particularly in aging, urban populations-and smoking still widespread in lower-income countries, the incidence of PAD continues to rise.

In March 2025, an Intermountain Health study presented at the ACC conference revealed that only 29.6% of women and 33.5% of men with symptomatic peripheral artery disease received full guideline-directed therapy. Among 7,522 patients tracked, the mortality rate exceeded 50%, underscoring severe gaps in diagnosis and treatment. Despite similar referral rates, women were less likely to receive optimal care. The study emphasized the need for improved screening protocols and focused PAD management.

Rapid innovation in endovascular technologies is reshaping treatment strategies and reinforcing market momentum. Next-generation tools such as drug-coated balloons, atherectomy systems, and bioresorbable stents offer improved efficacy, fewer complications, and shorter recovery times. These solutions are increasingly favored for treating complex lesions precisely while reducing restenosis and the need for repeat interventions. In March 2025, a study in Scientific Reports introduced DBMedDet, a deep-learning model that improved stent placement accuracy during endovascular procedures. With high precision (mAP 0.841) and real-time detection (127 FPS), it outperformed YOLO models in identifying stent boundaries across coronary, peripheral, and cerebrovascular cases.

Population aging further amplifies the market potential for PAD interventions, with individuals over 65 facing significantly elevated risk. Age-related arterial stiffening and the accumulation of comorbidities make this demographic especially vulnerable. In March 2025, the Aging Journal published findings from the Long Life Family Study showing individuals from long-lived families have a significantly lower risk of PAD. PAD prevalence among offspring of these families was only 1%, versus an expected 12%. Researchers linked this to protective genetic traits and healthier vascular profiles, identifying four genomic regions potentially tied to PAD resistance.

Global Peripheral Artery Disease Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global peripheral artery disease market report based on device type, anatomical site, end use, and region:

  • Device Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Endovascular Devices
  • Surgical Devices
  • Anatomical Site Outlook (Revenue, USD Million, 2021 - 2033)
  • Aortoiliac
  • Femoropopliteal
  • Tibial
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Outpatient Facilities
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-660-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Device Type
    • 1.2.2. Anatomical Site
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Device Type Segment
    • 2.2.2. Anatomical Site Segment
    • 2.2.3. End Use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Peripheral Artery Disease Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of diabetes and smoking
      • 3.2.1.2. Advancements in endovascular technologies
      • 3.2.1.3. Growing elderly population and PAD risk
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced revascularization procedures
      • 3.2.2.2. Limited access to PAD treatment in low-income regions
  • 3.3. Peripheral Artery Disease Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Peripheral Artery Disease Market: Device Type Estimates & Trend Analysis

  • 4.1. Peripheral Artery Disease Market: Device Type Dashboard
  • 4.2. Peripheral Artery Disease Market: Device Type Movement Analysis
  • 4.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by Device Type, 2021 - 2033 (USD Million)
  • 4.4. Endovascular Devices
    • 4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.5. Surgical Devices
    • 4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. Peripheral Artery Disease Market: Anatomical Site Estimates & Trend Analysis

  • 5.1. Peripheral Artery Disease Market: Anatomical Site Dashboard
  • 5.2. Peripheral Artery Disease Market: Anatomical Site Movement Analysis
  • 5.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by Anatomical Site, 2021 - 2033 (USD Million)
  • 5.4. Aortoiliac
    • 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.5. Femoropopliteal
    • 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.6. Tibial
    • 5.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Peripheral Artery Disease Market: End Use Estimates & Trend Analysis

  • 6.1. Peripheral Artery Disease Market: End Use Dashboard
  • 6.2. Peripheral Artery Disease Market: End Use Movement Analysis
  • 6.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.5. Outpatient Facilities
    • 6.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Peripheral Artery Disease Market: Regional Estimates & Trend Analysis by Country, Device Type, Anatomical Site & End Use

  • 7.1. Global Peripheral Artery Disease Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2021 - 2033
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/ reimbursement structure
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Japan market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.7.3. South Africa
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. UAE market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. BD
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bentley InnoMed
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Scitech Medical
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Abbott Laboratories
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Boston Scientific Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. W. L. Gore & Associates, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Medtronic
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Cook
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Terumo Corporation
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. iVascular
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Getinge AB
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Biotronik SE & Co KG
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-660-5

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 4 Global peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million
  • Table 5 Global peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 6 Global peripheral artery disease market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 9 North America peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 10 North America peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 11 U.S. peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 12 U.S. peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 13 U.S. peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Canada peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 15 Canada peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 16 Canada peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Mexico peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 18 Mexico peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 19 Mexico peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 22 Europe peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 23 Europe peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 24 UK peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 25 UK peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 26 UK peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 28 Germany peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 29 Germany peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 30 France peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 31 France peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 32 France peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Italy peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 34 Italy peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 35 Italy peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Spain peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 37 Spain peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 38 Spain peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Denmark peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 40 Denmark peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 41 Denmark peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Sweden peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 43 Sweden peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 44 Sweden peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Norway peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 46 Norway peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 47 Norway peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Japan peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 53 Japan peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 54 Japan peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 55 China peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 56 China peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 57 China peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 58 India peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 59 India peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 60 India peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Australia peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 62 Australia peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 63 Australia peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 64 Australia peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Thailand peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 66 Thailand peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 67 Thailand peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 68 South Korea peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 69 South Korea peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 70 South Korea peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Latin America peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 72 Latin America peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 73 Latin America peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 74 Latin America peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Brazil peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 76 Brazil peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 77 Brazil peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 78 Argentina peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 79 Argentina peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 80 Argentina peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 81 MEA peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 82 MEA peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 83 MEA peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 84 MEA peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 85 South Africa peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 86 South Africa peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 87 South Africa peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 90 Saudi Arabia peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 91 UAE peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 92 UAE peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 93 UAE peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 94 Kuwait peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 95 Kuwait peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 96 Kuwait peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 97 Participant's overview
  • Table 98 Financial performance
  • Table 99 Key companies undergoing expansions
  • Table 100 Key companies undergoing acquisitions
  • Table 101 Key companies undergoing collaborations
  • Table 102 Key companies launching new products
  • Table 103 Key companies undergoing partnerships
  • Table 104 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Peripheral artery disease market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Peripheral artery disease market revenues, 2024 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Peripheral artery disease market Device type outlook:
  • Fig. 14 Peripheral artery disease market: Device type movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global endovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 17 Global surgical devices market, 2021 - 2033 (USD Million)
  • Fig. 18 Peripheral artery disease market Anatomical site outlook:
  • Fig. 19 Peripheral artery disease market: Anatomical site movement analysis
  • Fig. 20 Global aortoiliac market, 2021 - 2033 (USD Million)
  • Fig. 21 Global femoropopliteal market, 2021 - 2033 (USD Million)
  • Fig. 22 Global tibial market, 2021 - 2033 (USD Million)
  • Fig. 23 Peripheral artery disease market end use outlook:
  • Fig. 24 Peripheral artery disease market: end use movement analysis
  • Fig. 25 Global hospitals market, 2021 - 2033 (USD Million)
  • Fig. 26 Global outpatient facilities market, 2021 - 2033 (USD Million)
  • Fig. 27 Global others market, 2021 - 2033 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 31 Canada peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 33 Europe peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 34 Germany peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 35 UK peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 36 France peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 37 Italy peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 38 Spain peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 39 Sweden peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 40 Denmark peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 41 Norway peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 42 Asia Pacific peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 43 Japan peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 44 China peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 45 India peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 46 Australia peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 47 Thailand peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 48 South Korea peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 49 Latin America peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 50 Brazil peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 51 Argentina peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 52 MEA peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 53 South Africa peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 54 Saudi Arabia peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 55 UAE peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 56 Kuwait peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 57 Market Participant Categorization
  • Fig. 58 Strategy mapping
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!